BeStock  
Stocks › Biotechnology › NUVB

Nuvation Bio NUVB

US equityMarket cap rank #2962Biotechnology
$3.80 −$0.01 (-0.26%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $3.80 0.00%
Open$3.77
Prev close$3.81
Day range$3.72 – $3.91
Volume6.85M
Market cap$1.34B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership69.1%+1.84 pts vs. prior quarter
Institutions holding294+7 vs. prior quarter
Insider trades (recent)33 buys / 17 sellsNet buying
Short interest17.66% of floatDays to cover 12.5 · as of 30 Oct 2026
Short-sale volume share26.7%5-day average of daily volume

Short-sale volume as % of daily volume

15%22%28%35%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$624.3K (14 inflow days, 6 outflow days).

Net flow by order size, last 20 sessions

−$4.4MSuper+$3.7MBig−$3.1MMid−$4.4MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 51.0% of shares outstanding.

Largest holders

  • David Hung17.08%
  • FMR14.92%
  • BlackRock8.19%
  • Decheng Capital LLC7.35%
  • Vanguard Capital Management, LLC3.44%
  • Omega Fund Management, LLC2.29%
  • Laurion Capital Management LP2.18%
  • State Street Global Advisors2.15%

By investor type

  • Mutual Fund44.15%
  • Individual/Insider17.43%
  • VC/PE Fund10.09%
  • Hedge Fund8.96%
  • Public Company2.86%
  • Family Office/Trust1.37%
  • Private Company1.09%
  • Government Pension Fund0.32%

Reported short interest has risen from 15.16% to 17.66% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Putnam LLC Mutual Fund 2026/Q3 +1,603,403 0.5%
BNP Paribas Financial Markets SNC Private Company 2026/Q3 +1,494,179 0.4%
BlackRock Mutual Fund 2026/Q3 +1,293,607 8.2%
Squarepoint OPS LLC Hedge Fund 2026/Q3 +863,626 0.3%
JPMorgan Chase & Co. Public Company 2026/Q3 +828,608 0.3%
Connor, Clark & Lunn Investment Management Ltd. Mutual Fund 2026/Q3 +780,088 0.7%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +735,322 0.2%
Invesco Capital Management LLC Mutual Fund 2026/Q3 +714,819 0.3%
Essex Investment Management Company, LLC Mutual Fund 2026/Q3 +673,830 0.4%
Morgan Stanley Public Company 2026/Q3 +620,073 0.6%
ACT Capital Management Hedge Fund 2026/Q3 +579,500 0.3%
Mizuho Financial Group, Inc. Public Company 2026/Q3 +503,376 0.1%
Barclays PLC Public Company 2026/Q3 +438,904 0.2%
FMR Mutual Fund 2026/Q3 +438,189 14.9%
BlackRock Mutual Fund 2026/Q3 +2,530,463 7.9%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
18 Aug 2026 Gary Hattersley Chief Scientific Officer Derivative Exercise and Sale -100,000 $7.09 –
14 Jul 2026 Philippe Sauvage CFO & Principal Financial Officer Derivative Exercise and Retained +40,000 $2.17 54,131
22 Jun 2026 Kerry Wentworth Chief Regulatory Officer Derivative Exercise and Sale -63,000 $6.02 53,000
22 Jun 2026 Stacy Markel Chief Human Resources Officer Derivative Exercise and Sale -125,000 $6.03 32,591
22 Jun 2026 Philippe Sauvage CFO & Principal Financial Officer Derivative Exercise and Sale -47,668 $6.01 12,673
22 Jun 2026 Moses Makunje VP of Finance and Principal Accounting & Financial Officer Intent to Sell (Form 144) -47,668 $5.76 –
8 Jun 2026 Robert Mashal Independent Director Open Market Acquisition +25,000 $4.73 225,000
20 May 2026 Kathryn Falberg Independent Director Other Derivative Acquisition +123,397 $4.79 123,397
20 May 2026 Kim Blickenstaff Independent Director Other Derivative Acquisition +123,397 $4.79 123,397
20 May 2026 Robert Bazemore Lead Independent Director Other Derivative Acquisition +123,397 $4.79 123,397
20 May 2026 Robert Mashal Independent Director Other Derivative Acquisition +123,397 $4.79 123,397
20 May 2026 William Vernon Independent Director Other Derivative Acquisition +123,397 $4.79 123,397
20 May 2026 Xiangmin Cui Independent Director Other Derivative Acquisition +123,397 $4.79 123,397
16 Apr 2026 Kerry Wentworth Chief Regulatory Officer Derivative Exercise and Sale -36,750 $5.01 53,000
16 Apr 2026 Dongfang Liu Derivative Exercise and Sale -50,000 $5.02 18,000
5 Apr 2026 Kerry Wentworth Chief Regulatory Officer Derivative Exercise and Sale -200,000 $4.52 53,000
26 Feb 2026 David Hung Chairperson & CEO Other Derivative Acquisition +1,995,012 $5.91 1,995,012
26 Feb 2026 Kerry Wentworth Chief Regulatory Officer Other Derivative Acquisition +748,130 $5.91 748,130
26 Feb 2026 Xiangmin Cui Independent Director Other Derivative Acquisition +76,923 $5.91 76,923
26 Feb 2026 Stacy Markel Chief Human Resources Officer Other Derivative Acquisition +748,130 $5.91 748,130

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 61,999,741 17.7% 12.5
15 Oct 2026 63,220,203 18.0% 9.7
30 Sep 2026 58,862,812 16.8% 13.9
15 Sep 2026 58,173,586 16.6% 10.9
31 Aug 2026 54,264,998 15.5% 10.7
14 Aug 2026 53,222,212 15.2% 8.9

Discussion

No comments yet — be the first to weigh in on NUVB.

Sign in to join the discussion.

Scroll to Top